All news

Eli Lilly rises 2.35% premarket after Jefferies lifts target to Street-high

Yahoo Finance · · AI-summarised by FinFlash

Eli Lilly shares rose 2.35% to

So What?

Supports the GLP-1 trade and Lilly's premium valuation; Jefferies' view that GLP-1s do not mainly compete on price eases fears of steep international price cuts, relevant also for Novo Nordisk.

Read original source

LLY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.